The state Supreme Court waded through lengthy arguments Tuesday in a case in which the state of Pennsylvania has alleged two pharmaceutical companies inflated the price of their drugs at the government’s expense.
In the case of Commonwealth v. TAP Pharmaceutical Products, two pharmaceutical companies, Johnson & Johnson and Bristol-Myers Squibb, are appealing combined verdicts against them of roughly $80 million. The state alleged the companies inflated their drugs’ prices such that the government overpaid medical providers in prescription drug reimbursements.
